CytomX Therapeutics, Inc. CTMX
2.13 USD +0.15 (+7.58%)
At closeNov 11, 2026, 6:00 PM EST
2.16 +0.03 +1.41%
After hours · Nov 11, 6:00 PM ET
1.97 Day range 2.17
1.90 52-week range 8.21
- YTD
- -50.00%
- 1 year
- -48.05%
CTMX revenue history
Revenue is income from the company’s ordinary business activities.
76,201,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 76,201,000 | -61,902,000 | -44.82% |
| FY 2024 | 2024-12-31 | 138,103,000 | 36,889,000 | 36.45% |
| FY 2023 | 2023-12-31 | 101,214,000 | 48,051,000 | 90.38% |
| FY 2022 | 2022-12-31 | 53,163,000 | 15,851,000 | 42.48% |
| FY 2021 | 2021-12-31 | 37,312,000 | -31,115,000 | -45.47% |
| FY 2020 | 2020-12-31 | 68,427,000 | 41,525,000 | 154.36% |
| FY 2019 | 2019-12-31 | 26,902,000 | -32,600,000 | -54.79% |
| FY 2018 | 2018-12-31 | 59,502,000 | -12,121,000 | -16.92% |
| FY 2017 | 2017-12-31 | 71,623,000 | 56,580,000 | 376.12% |
| FY 2016 | 2016-12-31 | 15,043,000 | 7,331,000 | 95.06% |
| FY 2015 | 2015-12-31 | 7,712,000 | 2,635,000 | 51.90% |
| FY 2014 | 2014-12-31 | 5,077,000 | 4,189,000 | 471.73% |
| FY 2013 | 2013-12-31 | 888,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-08T14:24:22.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.